Skip to main content
. Author manuscript; available in PMC: 2012 Jul 5.
Published in final edited form as: Circulation. 2011 Jun 20;124(1):17–23. doi: 10.1161/CIRCULATIONAHA.110.003954

Table 4. Baseline characteristics of PAD subjects according to number of secondary prevention treatments.

Characteristic No treatment* (n=244) One treatment (n=129) Multiple treatments (n=77)
Age, years (mean) 63.7 (1.0) 69.8 (1.6) 70.4 (1.8)
Gender (% male) 32.2 (3.8) 33.8 (5.5) 45.2 (6.6)
Race (% Non-Hispanic white) 70.7 (3.6) 83.6 (2.4) 87.9 (3.8)
Diabetes (%) 15.0 (2.1) 21.7 (4.3) 22.1 (5.6)
Hypertension (%) 59.0 (4.4) 76.8 (5.8) 89.7 (3.9)
Hyperlipidemia (%) 43.1 (3.7) 61.1 (5.9) 72.4 (6.3)
Smoking (% current or former) 59.2 (5.0) 62.8 (6.6) 68.4 (6.3)
Chronic kidney disease (%) 19.8 (2.9) 32.2 (4.6) 45.3 (7.6)
Systolic blood pressure, mmHg (mean) 138.2 (1.4) 142.3 (3.7) 137.1 (2.3)
Body mass index, kg/m2 (mean) 28.0 (0.6) 28.9 (0.6) 29.8 (1.3)
Ankle-brachial index (mean) 0.80 (0.01) 0.76 (0.01) 0.74 (0.02)
High school education (%) 69.6 (3.5) 70.1 (4.8) 63.8 (6.6)
Socioeconomic status (based on PIR)
 Income below poverty level (%) 21.1 (4.0) 11.4 (2.3) 5.3 (1.8)
 Income 1-2 times poverty level (%) 29.2 (3.3) 27.9 (5.1) 26.9 (6.7)
 Income 2-3 times poverty level (%) 17.4 (4.7) 28.2 (5.7) 23.4 (5.9)
 Income 3-4 times poverty level (%) 12.4 (3.1) 8.2 (3.5) 8.3 (4.3)
 Income >5 times poverty level (%) 19.9 (5.2) 24.2 (4.9) 36.1 (7.9)
Low socioeconomic status (Income < 2 times poverty level) (%) 50.3 (4.8) 39.4 (5.4) 32.2 (6.9)
Uninsured (%) 13.9 (2.9) 2.6 (1.5) 0.8 (0.8)
*

includes anti-platelet therapy, statin use, and/or ACE inhibitor or ARB;

PIR = poverty-income ratio